Trial Profile
Levofloxacin (Cravit) versus Moxifloxacin-concentration of epithelial lining fluid in patients with idiopathic pulmonary fibrosis
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 01 Aug 2012
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Moxifloxacin (Primary)
- Indications Bacterial infections; Idiopathic pulmonary fibrosis; Respiratory tract infections
- Focus Pharmacokinetics
- 01 Aug 2012 New trial record